4R7X
Crystal structure of N-lobe of human ARRDC3(1-180)
Summary for 4R7X
| Entry DOI | 10.2210/pdb4r7x/pdb |
| Related | 4R7V |
| Descriptor | Arrestin domain-containing protein 3, PHOSPHATE ION (3 entities in total) |
| Functional Keywords | arrestin fold, gpcr downregulation, beat 2 adrenergic receptor, protein binding |
| Biological source | Homo sapiens (human) |
| Cellular location | Cytoplasm : Q96B67 |
| Total number of polymer chains | 2 |
| Total formula weight | 42827.36 |
| Authors | Qi, S.,Hurley, J. (deposition date: 2014-08-28, release date: 2014-10-01, Last modification date: 2024-02-28) |
| Primary citation | Qi, S.,O'Hayre, M.,Gutkind, J.S.,Hurley, J.H. Insights into beta 2-adrenergic receptor binding from structures of the N-terminal lobe of ARRDC3. Protein Sci., 23:1708-1716, 2014 Cited by PubMed Abstract: ARRDC3 is one of six known human α-arrestins, and has been implicated in the downregulation of the β2-adrenergic receptor (β2AR). ARRDC3 consists of a two-lobed arrestin fold and a C-terminal tail containing two PPYX motifs. In the current model for receptor downregulation by ARRDC3, the arrestin fold portion is thought to bind the receptor, while the PPXY motifs recruit ubiquitin ligases of the NEDD4 family. Here we report the crystal structures of the N-terminal lobe of human ARRDC3 in two conformations, at 1.73 and 2.8 Å resolution, respectively. The structures reveal a large electropositive region that is capable of binding phosphate ions of crystallization. Residues within the basic patch were shown to be important for binding to β2AR, similar to the situation with β-arrestins. This highlights potential parallels in receptor recognition between α- and β-arrestins. PubMed: 25220262DOI: 10.1002/pro.2549 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.61 Å) |
Structure validation
Download full validation report






